Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

Related Articles by Review for PubMed (Select 17940453)

1.

Type 1 diabetes intervention trials 2007: where are we and where are we going?

Haller MJ, Gottlieb PA, Schatz DA.

Curr Opin Endocrinol Diabetes Obes. 2007 Aug;14(4):283-7. Review.

PMID:
17940453
2.

Prevention strategies for type 1 diabetes mellitus: current status and future directions.

Winter WE, Schatz D.

BioDrugs. 2003;17(1):39-64. Review.

PMID:
12534319
3.

Vaccine therapies for the prevention of type 1 diabetes mellitus.

Petrovsky N, Silva D, Schatz DA.

Paediatr Drugs. 2003;5(9):575-82. Review.

PMID:
12956615
4.

Efforts to prevent and halt autoimmune beta cell destruction.

Haller MJ, Atkinson MA, Schatz DA.

Endocrinol Metab Clin North Am. 2010 Sep;39(3):527-39. doi: 10.1016/j.ecl.2010.05.006. Review.

5.

Immunotherapeutic approaches to prevent, ameliorate, and cure type 1 diabetes.

Aly T, Devendra D, Eisenbarth GS.

Am J Ther. 2005 Nov-Dec;12(6):481-90. Review.

PMID:
16280641
6.

The pancreas in human type 1 diabetes: providing new answers to age-old questions.

Atkinson MA, Gianani R.

Curr Opin Endocrinol Diabetes Obes. 2009 Aug;16(4):279-85. doi: 10.1097/MED.0b013e32832e06ba. Review.

PMID:
19502978
7.

Immune modulation in type 1 diabetes mellitus using DiaPep277: a short review and update of recent clinical trial results.

Eldor R, Kassem S, Raz I.

Diabetes Metab Res Rev. 2009 May;25(4):316-20. doi: 10.1002/dmrr.942. Review.

PMID:
19267355
8.

Update on global intervention studies in type 1 diabetes.

Chiang JL, Haller MJ, Schatz DA.

Endocrinol Metab Clin North Am. 2012 Dec;41(4):695-712. doi: 10.1016/j.ecl.2012.07.003. Review.

PMID:
23099265
9.

Can insulin therapy delay or prevent insulin-dependent diabetes mellitus?

Kakka R, Koda-Kimble MA.

Pharmacotherapy. 1997 Jan-Feb;17(1):38-44. Review.

PMID:
9017764
10.
11.

Making progress: preserving beta cells in type 1 diabetes.

Gallagher MP, Goland RS, Greenbaum CJ.

Ann N Y Acad Sci. 2011 Dec;1243:119-34. doi: 10.1111/j.1749-6632.2011.06321.x. Review.

PMID:
22211897
12.

Therapies aimed at preservation or restoration of beta cell function in type 1 diabetes.

Keymeulen B.

Verh K Acad Geneeskd Belg. 2008;70(2):85-103. Review.

PMID:
18630722
13.

Diabetes vaccines: a future to be realized.

Lin-Su K, Kukreja A, Maclaren NK.

Diabetes Technol Ther. 2001 Fall;3(3):451-61. Review.

PMID:
11762523
14.

[Prevention strategies of type 1 diabetes: the focus in 2003].

Philips JC, Scheen AJ; Registre Belge du Diab├Ęte.

Rev Med Liege. 2003 Apr;58(4):211-9. Review. French.

PMID:
12868323
15.

Therapeutic targets for the prevention of type 1 diabetes mellitus.

Singh N, Palmer JP.

Curr Drug Targets Immune Endocr Metabol Disord. 2005 Jun;5(2):227-36. Review.

PMID:
16089357
16.

Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.

Eldor R, Cohen IR, Raz I.

Int Rev Immunol. 2005 Sep-Dec;24(5-6):327-39. Review.

PMID:
16318985
17.

Do immunotherapy and beta cell replacement play a synergistic role in the treatment of type 1 diabetes?

Li DS, Warnock GL, Tu HJ, Ao Z, He Z, Lu H, Dai LJ.

Life Sci. 2009 Oct 7;85(15-16):549-56. doi: 10.1016/j.lfs.2009.08.016. Epub 2009 Sep 9. Review.

PMID:
19747492
18.

Challenges in developing endpoints for type 1 diabetes intervention studies.

Cernea S, Raz I, Herold KC, Hirshberg B, Roep BO, Schatz DA, Fleming GA, Pozzilli P, Little R, Schloot NC, Leslie RD, Skyler JS, Palmer JP; D-Cure Workshop.

Diabetes Metab Res Rev. 2009 Nov;25(8):694-704. doi: 10.1002/dmrr.1002. Review.

PMID:
19771545
19.

Gene therapy in type 1 diabetes.

Bagley J, Paez-Cortez J, Tian C, Iacomini J.

Crit Rev Immunol. 2008;28(4):301-24. Review.

PMID:
19166382
20.

[Heterogeneity of type 1 diabetes mellitus].

Dib SA.

Arq Bras Endocrinol Metabol. 2008 Mar;52(2):205-18. Review. Portuguese.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk